Novel hydrophilic ligands to selectively separate Am(III) are synthesized: 3,3′-([2,2′-bipyridine]-6,6′-diylbis(1H-1,2,3-triazole-4,1-diyl))bis(propan-1-ol) (PrOH-BPTD) and 3,3′-([2,2′-bipyridine]-6,6′-diylbis(1H-1,2,3-triazole-4,1-diyl))bis-(ethan-1-ol) (EtOH-BPTD). The complexation of An(III) and Ln(III) with PrOH-and EtOH-BPTD is studied by time-resolved laser fluorescence spectroscopy. [ML 2 ] 3+ is found for both Cm(III) and Eu(III), while [ML] 3+ is only formed with Cm(III). Stability constants show a preferential coordination of Cm(III) over Eu(III) with PrOH-BPTD being the stronger ligand. The distribution of Am(III), Cm(III), and Ln(III) between an organic phase containing the extracting agent N,N,N′,N′-tetra-n-octyl-3-oxapentanediamide (TODGA) and aqueous phases containing PrOH-BPTD is studied as a function of time and temperature as well as the TODGA, BPTD, and HNO 3 concentrations. A system composed of 0.2 mol/L TODGA and 0.04 mol/L PrOH-BPTD in 0.33−0.39 mol/L HNO 3 allows for selective Am(III) back-extraction into the aqueous phase while keeping Cm(III) and Ln(III) in the organic phase, marking PrOH-BPTD as an excellent complexant for an optimized AmSel process (Am(III) selective extraction).
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.